SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-003470
Filing Date
2015-08-07
Accepted
2015-08-07 16:17:31
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 491683
2 ex31-1.htm EX-31.1 16174
3 ex32-1.htm EX-32.1 5979
  Complete submission text file 0001493152-15-003470.txt   3420703

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20150630.xml EX-101.INS 553806
5 XBRL SCHEMA FILE lixt-20150630.xsd EX-101.SCH 56748
6 XBRL CALCULATION FILE lixt-20150630_cal.xml EX-101.CAL 34249
7 XBRL DEFINITION FILE lixt-20150630_def.xml EX-101.DEF 176997
8 XBRL LABEL FILE lixt-20150630_lab.xml EX-101.LAB 360475
9 XBRL PRESENTATION FILE lixt-20150630_pre.xml EX-101.PRE 234840
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 151037734
SIC: 2834 Pharmaceutical Preparations